KalVista Pharmaceuticals Cash Flow Statement (2014-2025) | KALV

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Dec2024 Apr2025
Operating Activities
Net Income -2.02M-2.52M-3.92M-5.18M-5.83M-4.99M-5.66M-6.60M-5.11M-4.01M-8.11M-5.08M-5.45M-5.94M-4.33M-2.90M-6.92M-4.69M-5.94M-10.88M-8.97M-8.78M-12.35M-8.59M-29.03M-44.65M-40.44M-42.27M
Depreciation and Depletion 0.01M0.03M
Share-based Compensation 0.06M0.05M0.10M0.12M0.04M0.29M0.34M0.37M0.00M0.06M0.16M0.17M0.22M0.27M0.28M0.28M0.35M0.98M0.80M0.85M1.07M1.16M1.12M1.09M1.19M3.25M3.21M2.71M12.74M3.04M3.00M3.64M
Gains from Investment Securities 0.08M0.34M-0.52M-0.00M-0.06M0.51M0.03M0.10M0.10M0.08M0.07M0.31M0.59M0.22M0.20M0.32M0.65M0.37M
Asset Writedowns and Impairment 1.46M
Cash from Operations -1.75M-1.94M-3.22M-4.05M-6.44M-5.31M-5.07M-5.08M-5.65M-4.19M-11.24M-2.64M-4.45M-7.26M28.22M-5.96M-6.21M-8.79M-10.86M-10.51M-11.28M-7.81M-13.11M-12.62M-3.59M-26.73M-19.82M-27.57M-15.11M-40.22M-39.64M-40.36M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M0.71M0.05M0.01M0.01M0.01M0.04M0.04M0.06M0.06M0.07M0.06M0.02M0.01M0.00M0.01M0.01M0.00M
Amortization of Deferred Charges 0.08M0.07M0.14M0.14M0.14M
Depreciation & Amortization (CF) 0.01M0.01M0.02M0.03M0.03M0.03M0.04M0.03M0.01M0.01M0.01M0.01M0.03M0.05M0.05M0.05M0.05M0.10M0.10M0.12M0.12M0.13M0.13M0.13M0.13M0.19M0.20M0.21M0.22M0.22M0.23M0.26M
Change in Working Capital
Change in Account Payables 0.02M0.25M0.09M1.01M-0.22M-0.29M-0.15M-0.27M1.00M-1.07M-1.88M0.36M0.77M-0.91M0.69M-0.33M1.13M0.96M-0.34M-0.21M0.39M-0.95M0.69M-1.14M0.04M0.11M0.06M-1.94M6.10M1.50M-5.86M-1.39M
Change in Accured Expenses 0.12M0.22M0.64M0.15M-0.09M-0.39M0.04M-0.25M-0.75M-0.38M-0.44M-0.37M-0.18M0.55M-0.03M0.80M0.16M-0.09M0.35M2.25M-1.12M0.55M-0.20M0.72M0.54M-1.24M4.01M2.87M-2.44M-1.78M5.04M8.12M
Other Working Capital Changes 0.07M-0.01M-0.02M0.44M0.49M-0.04M-0.35M-0.09M0.09M-0.36M0.96M-0.61M0.09M0.55M33.17M-4.57M-3.72M-5.59M-3.89M-2.93M-3.37M-3.92M-1.58M-3.82M-1.30M1.00M-1.76M-0.14M1.44M0.78M-2.10M10.48M
Investing Activities
Capital Expenditures 0.00M0.07M0.01M0.18M0.08M0.02M0.38M0.18M0.04M0.02M0.01M0.01M0.11M0.05M0.18M1.08M0.56M0.22M0.02M0.28M0.10M0.11M0.01M0.02M0.01M0.20M0.09M0.11M0.06M0.09M0.23M
Change in Acquisitions & Divestments 10.70M18.21M21.52M12.32M14.72M15.34M45.39M32.53M11.56M15.48M38.23M48.88M20.21M
Cash from Investing Activities -0.00M-0.07M-0.01M-0.18M-0.08M-0.02M-1.09M-0.18M-0.04M-0.02M34.13M-0.01M-0.11M-0.05M-0.18M-1.08M-0.56M-0.22M-54.59M-14.05M-1.53M-1.51M9.77M10.03M5.51M19.61M28.56M-6.70M-126.19M37.16M48.67M-3.33M
Financing Activities
Other financing activities 0.61M
Cash from Financing Activities 1.25M-0.09M5.38M3.51M68.72M-0.18M0.01M-0.05M-0.01M4.95M82.78M0.06M0.15M11.40M0.14M0.04M0.00M0.05M0.20M0.13M0.28M150.10M3.00M0.29M4.66M
Additional items
Exchange Rate Effect -0.44M-0.74M-0.08M0.10M0.06M-0.07M2.56M-0.57M-1.16M-0.73M0.62M0.06M-0.49M0.80M0.19M-0.24M0.25M0.08M-0.60M-0.62M-0.07M0.12M0.41M3.36M
Change in Cash -0.51M-2.10M2.15M-0.72M62.20M-5.50M-6.16M-5.27M-6.14M-4.94M22.81M-2.55M-4.49M1.67M30.55M-7.62M-2.98M73.05M-64.77M-24.34M-1.90M-8.39M-3.10M-2.83M2.23M-6.83M8.26M-34.61M8.73M0.06M9.73M-35.67M
Beginning Cash Balance 9.78M9.28M7.18M3.90M3.90M3.18M65.38M59.88M53.86M21.76M15.63M10.69M33.50M30.95M26.46M28.13M58.68M51.05M48.07M121.12M56.34M32.01M30.11M21.72M18.61M15.79M16.17M17.73M56.24M49.41M57.67M23.06M31.79M31.85M182.33M35.67M
Free Cash Flow -1.75M-2.01M-3.23M-4.23M-6.52M-5.33M-5.45M-5.27M-5.70M-4.20M-11.25M-2.65M-4.56M-7.31M28.04M-7.04M-6.78M-9.01M-10.88M-10.79M-11.37M-7.93M-13.11M-12.63M-3.61M-26.74M-20.02M-27.66M-15.21M-40.28M-39.74M-40.60M
Net Cash Flow -0.51M-2.10M2.15M-0.72M62.20M-5.50M-6.16M-5.27M-5.70M-4.20M22.89M-2.65M-4.56M-7.31M27.99M-7.05M-1.83M73.78M-65.39M-24.40M-1.41M-9.19M-3.29M-2.59M1.97M-6.91M8.86M-33.99M8.81M-0.06M9.33M-39.03M